Open tender · Germany · Contract notice
Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Eribulin, ATC L01XX41
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Eribulin, ATC L01XX41”. Bids close on 16 May 2027.
The work
Non-exclusive discount agreements for Eribulin parenteral preparations in oncology for the Bavarian region.
- Identical and non-negotiable discount agreements
- Proof of reliability via signed declaration
- Submission of signed contract and OHV_8c_Bayern_Festlegung_PZN file
Key facts
- Contract period
- From 01.08.2025 to 31.07.2027, with possible termination with 8 weeks' notice.
- Evaluation
- Not applicable as this is an open-house model, not a competitive tender.
What it takes to qualify
Worth a closer look
- The tender is for an 'open-house' model, not a formal tender, and thus does not fall under procurement law.
- The requirement for a 'non-blacklisting declaration' is not explicitly stated.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Eigenerklärung zur ZuverlässigkeitUnsigned declaration to be downloaded from the tender documents
- VertragSigned contract form
- OHV_8c_Bayern_Festlegung_PZNElectronic file to be submitted